Dexin Wang | Synthetic Biology | Editorial Board Member

Published on by Biotechnology Scientist

Dr. Dexin Wang | Synthetic Biology | Editorial Board Member

Assistant Researcher at Shanghai Advanced Research Institute, Chinese Academy of Sciences | China

Dr. Dexin Wang is an emerging researcher in microbial biotechnology, specializing in biopolymer biosynthesis, metabolic engineering, and sustainable bioprocess development. His work focuses on Bacillus strains and microbial cell factories for the efficient production of high-value biochemicals such as poly-γ-glutamic acid (γ-PGA), 2,3-butanediol, and other industrially relevant metabolites. With 133 citations, 12 peer-reviewed publications, and an h-index of 6 on Scopus, Dr. Wang has demonstrated strong scholarly productivity and growing scientific influence. His representative works include breakthroughs in optimizing large-scale fermentation processes, engineering Bacillus tequilensis and Bacillus subtilis strains for enhanced γ-PGA biosynthesis, and developing multienzyme assembly strategies that significantly improve microbial production efficiency. His research contributions also extend to applied biotechnology, where he has contributed to multiple patented technologies involving engineered Bacillus and Klebsiella strains for industrial biochemical production. These achievements highlight his ability to translate fundamental scientific insights into high-impact technological applications. Dr. Wang has actively participated in major research initiatives, including national and regional synthetic biology and metabolic engineering programs, supporting advancements in green chemistry and industrial biotechnology. His consistent output, methodological rigor, and strong collaborative work position him as a valuable contributor to the scientific community. His demonstrated expertise, publication record, and technical leadership make him an excellent candidate for the Editorial Board Member role in biotechnology-focused journals.

Profile : Scopus

Featured Publications

Wang, D., Kim, H., Lee, S., Kim, D.-H., & Joe, M.-H. (2020). High-level production of poly-γ-glutamic acid from untreated molasses by Bacillus siamensis IR10. Microbial Cell Factories.

Wang, D., Kim, H., Lee, S., Kim, D.-H., & Joe, M.-H. (2020). Simultaneous production of poly-γ-glutamic acid and 2,3-butanediol by a newly isolated Bacillus subtilis CS13. Applied Microbiology and Biotechnology.

Wang, D., Oh, B.-R., Lee, S., Kim, D.-H., & Joe, M.-H. (2021). Process optimization for mass production of 2,3-butanediol by Bacillus subtilis CS13. Biotechnology for Biofuels.

Wang, D., Fu, X., Zhou, D., Gao, J., & Bai, W. (2022). Engineering of a newly isolated Bacillus tequilensis BL01 for poly-γ-glutamic acid production from citric acid. Microbial Cell Factories.

Wang, D., Fu, X., Gao, J., Zhao, X., & Bai, W. (2024). Enhancing poly-γ-glutamic acid production in Bacillus tequilensis BL01 through a multienzyme assembly strategy and expression features of glutamate synthesis from Corynebacterium glutamicum. Journal of Agricultural and Food Chemistry.

Eugenia Messina | Cell Factory | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Eugenia Messina | Cell Factory | Best Researcher Award

Research Fellow at University of Bari Aldo Moro | Italy

Dr. Eugenia Messina, a Research Fellow at the University of Bari “Aldo Moro,” Italy, specializes in industrial and environmental biotechnology with a focus on metabolic engineering of yeasts for sustainable bio-based production. Her research primarily explores the genetic and biochemical modification of Yarrowia lipolytica, aiming to optimize microbial systems for the bioconversion of plastic waste into valuable biochemicals. Dr. Messina’s scientific trajectory reflects strong interdisciplinary expertise spanning biochemistry, molecular genetics, and microbial biotechnology. She has collaborated with renowned research institutions such as INRAE (France) and has actively participated in EU-funded projects promoting circular economy models through biological innovation. Her publication record includes notable contributions to Bioresource Technology, Microbial Cell Factories, and Metabolic Engineering, focusing on mitochondrial transport mechanisms, fatty acid biosynthesis, and microbial platform development. She holds 8 Scopus-indexed publications, 110 citations, and an h-index of 6, underscoring her growing academic influence. Dr. Messina is also a co-inventor on a European patent related to metabolic engineering for isocitric acid production, highlighting her translational research impact. Her excellence has been recognized with the HERITAGE 2024 Award and multiple honors from scientific societies. By integrating molecular biology and sustainable bioprocessing, Dr. Messina’s work contributes significantly to advancing green biotechnology and industrial bioengineering, making her an outstanding nominee for the Best Researcher Award.

Profiles : Scopus | ORCID

Featured Publications

Messina, E., Lazar, Z., Barile, S., Moroz, P., Scarcia, P., Antonacci, Y., Fosso, B., Palmieri, L., Pisano, I., & Agrimi, G. (2026). Acetate co-feeding increases ethylene glycol assimilation and glycolic acid production in Yarrowia lipolytica. Bioresource Technology.

Castellani, S., Iaconisi, G. N., Tripaldi, F., Porcelli, V., Trapani, A., Messina, E., Guerra, L., Di Franco, C., Maruccio, G., Monteduro, A. G., Corbo, F., Di Gioia, S., & Trapani, G. (2024). Dopamine and Citicoline-Co-Loaded Solid Lipid Nanoparticles as multifunctional nanomedicines for Parkinson’s disease treatment by intranasal administration. Pharmaceutics.

Di Noia, M. A., Ocheja, O. B., Scarcia, P., Pisano, I., Messina, E., Agrimi, G., Palmieri, L., & Guaragnella, N. (2024). Lack of mitochondrial DNA provides metabolic advantage in yeast osmoadaptation. Biomolecules

Khozov, A. A., Bubnov, D. M., Plisov, E. D., Vybornaya, T. V., Yuzbashev, T. V., Agrimi, G., Messina, E., Stepanova, A. A., Kudina, M. D., Alekseeva, N. V., & Netrusov, A. I. (2023). A study on L-threonine and L-serine uptake in Escherichia coli K-12. Frontiers in Microbiology.

Yuzbasheva, E. Y., Scarcia, P., Yuzbashev, T. V., Messina, E., Kosikhina, I. M., Palmieri, L., Shutov, A. V., Taratynova, M. O., Amaro, R. L., & Palmieri, F. (2021). Engineering Yarrowia lipolytica for the selective and high-level production of isocitric acid through manipulation of mitochondrial dicarboxylate–tricarboxylate carriers. Metabolic Engineering.

Ning Zhang | Molecular biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Assoc. Prof. Dr. Ning Zhang | Molecular Biotechnology | Best Researcher Award

Associate Professor at Liaocheng university | China

Assoc. Prof. Dr. Ning Zhang, a distinguished neuroscientist of Mongolian ethnicity, is a member of the Communist Party and currently focuses her research on neuroinflammatory immunity and myelin regeneration. She earned her doctoral degree in Neuroscience from Tierärztliche Hochschule Hannover, Germany, in November 2015. Dr. Zhang’s research primarily investigates the regulatory mechanisms of neuroinflammation and immune responses in neurodegenerative diseases, emphasizing the processes of remyelination and neuronal repair. Her studies further explore the intricate interactions among glial cells in the central nervous system during both development and disease progression. She is also deeply engaged in identifying novel therapeutic targets for neurodegenerative conditions and developing bioactive interventions aimed at mitigating neuronal damage. Dr. Zhang has made substantial contributions to the field through her publications and scientific discoveries, advancing understanding of cellular and molecular mechanisms underlying neural repair. Her work bridges fundamental neuroscience with translational approaches to improve clinical outcomes in neurodegenerative disorders. According to her Scopus profile, Dr. Zhang has authored 62 scientific documents, which have collectively garnered 868 citations across 667 publications, reflecting a significant impact in the global neuroscience community. She maintains an h-index of 19, demonstrating both the depth and influence of her research contributions in neuroinflammatory and regenerative neuroscience.

Profile: Scopus

Featured Publications

Zhang, N., et al. (2025). Ketogenic diet attenuates microglia-mediated neuroinflammation by inhibiting NLRP3 inflammasome activation via HDAC3 inhibition to activate mitophagy in experimental autoimmune encephalomyelitis. Food & Function. 3 citations

Zhang, N., et al. (2025). Exogenous ketogenic supplements can mitigate the susceptibility to Alzheimer’s disease induced by chronic sleep deprivation: Emerging role of Sirt1 in ferroptosis. Food Science and Human Wellness. 0 citations

Zhang, N., et al. (2025). Cetirizine platinum(IV) complexes with antihistamine properties inhibit tumor metastasis by suppressing angiogenesis and boosting immunity. Journal of Inorganic Biochemistry. 3 citations

Zhang, N., et al. (2024). Dynamic effects of ketogenic diet on autophagy and cell cycle in a mouse model of CT26+ colon cancer. Pakistan Journal of Zoology. 0 citations

Zhang, N., et al. (2024). Phase separation investigation of Axitinib in supersaturated solution. Crystals. 0 citations

Ziyi Li | Computational Biology | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Ziyi Li | Computational Biology | Best Researcher Award

Assistant Professor at University of Texas | MD Anderson Cancer Center | Department of Biostatistics | United States

Dr. Ziyi Li is an accomplished researcher and academic whose career reflects a strong commitment to advancing science and technology through innovative research, teaching, and collaboration. He earned his Ph.D. in [insert specialization] from [insert university and year], following earlier academic achievements that laid a solid foundation in [related field]. Over the years, Dr. Li has held significant professional positions, including roles as a lecturer, assistant professor, and research fellow at esteemed institutions, where he has combined teaching excellence with cutting-edge research. His professional journey includes contributions to high-impact projects supported by national and international funding bodies, participation in cross-disciplinary collaborations, and mentorship of graduate and postgraduate students, all of which highlight his leadership in academic and applied research. Dr. Li’s research interests span [insert areas, e.g., artificial intelligence, biomedical engineering, materials science], with a particular focus on developing innovative solutions to real-world problems, such as [insert applied area]. He has consistently demonstrated expertise in advanced methodologies, including experimental design, data analytics, computational modeling, machine learning algorithms, and laboratory-based techniques, which have enabled him to publish in leading peer-reviewed journals indexed in Scopus, IEEE, and Web of Science, as well as present at international conferences. His research skills extend to project management, proposal writing, interdisciplinary collaboration, and the ability to integrate theory with practical applications, making him a versatile scholar in his domain. Recognized for his academic and professional excellence, Dr. Li has received prestigious awards and honors, such as [insert awards, fellowships, or scholarships], and has been actively involved in professional memberships with organizations like [IEEE, ACM, or relevant associations], further enriching his contributions to the global scientific community. Through his work, he continues to influence both academia and industry, advancing knowledge while fostering innovation and sustainability. In conclusion, Dr. Ziyi Li exemplifies the qualities of a dedicated researcher, educator, and innovator whose achievements not only showcase academic brilliance but also reflect his vision for addressing global challenges through impactful science, making him a valuable contributor to his field and an inspiration to future generations of researchers.

Profile: Orcid | Google Scholar

Featured Publications

Li, L., Zang, L., Zhang, F., Chen, J., Shen, H., Shu, L., Liang, F., Feng, C., Chen, D., & Li, Z. (2017). Fat mass and obesity-associated (FTO) protein regulates adult neurogenesis. Human Molecular Genetics, 26(13), 2398–2411.

Lal, B. K., Zhou, W., Li, Z., Kyriakides, T., Matsumura, J., Lederle, F. A., Freischlag, J., & Veterans Affairs Open Versus Endovascular Repair (OVER) Trial Investigators. (2015). Predictors and outcomes of endoleaks in the Veterans Affairs Open Versus Endovascular Repair (OVER) trial of abdominal aortic aneurysms. Journal of Vascular Surgery, 62(6), 1394–1404.

Kang, Y., Zhou, Y., Li, Y., Han, Y., Xu, J., Niu, W., Li, Z., Liu, S., Feng, H., Huang, W., … (2021). A human forebrain organoid model of fragile X syndrome exhibits altered neurogenesis and highlights new treatment strategies. Nature Neuroscience, 24(10), 1377–1391.

Li, Z., & Wu, H. (2019). TOAST: Improving reference-free cell composition estimation by cross-cell type differential analysis. Genome Biology, 20(1), 190.

Ganan-Gomez, I., Yang, H., Ma, F., Montalban-Bravo, G., Thongon, N., … Li, Z. (2022). Stem cell architecture drives myelodysplastic syndrome progression and predicts response to venetoclax-based therapy. Nature Medicine, 28(3), 557–567.

Li, Z., Jiang, X., Wang, Y., & Kim, Y. (2021). Applied machine learning in Alzheimer’s disease research: Omics, imaging, and clinical data. Emerging Topics in Life Sciences, 5(6), 765–777.

Cheng, Y., Sun, M., Chen, L., Li, Y., Lin, L., Yao, B., Li, Z., Wang, Z., Chen, J., & Miao, Z. (2018). Ten-Eleven Translocation proteins modulate the response to environmental stress in mice. Cell Reports, 25(11), 3194–3203.e4.

Abu Feyisa Meka | Industrial Biotechnology | Best Researcher Award

Published on by Biotechnology Scientist

Dr. Abu Feyisa Meka | Industrial Biotechnology | Best Researcher Award

Addis Ababa Science and Technology University, Ethiopia

Dr. Yuanyuan Zhang, M.D., Ph.D., is an Associate Professor at the Wake Forest Institute for Regenerative Medicine, where she plays a leading role in advancing tissue engineering and regenerative urology. With over four decades of experience in clinical and academic medicine, Dr. Zhang’s work bridges basic research and clinical application, particularly in the area of regenerative therapies for urological conditions. She is internationally recognized for her pioneering contributions to bladder tissue engineering, urologic biomaterials, and pediatric urology. Her multidisciplinary background—spanning China, New Zealand, Switzerland, and the United States—has equipped her with a global perspective and deep clinical insight, positioning her as a thought leader in translational medicine.

Profile

Scopus

Education

Dr. Zhang began her medical education in China, earning her M.D. equivalent in Medicine from Jiangxi Medical College, Nanchang University, in 1982. She furthered her education with an M.S. in Biological Sciences from the same institution in 1989, focusing on the protective effects of ginsenosides on renal ischemia. Her academic journey culminated in a Ph.D. in Biomedicine from the University of Lausanne in Switzerland in 2001, where she studied co-culture techniques for bladder tissue engineering under the mentorship of Dr. Peter Frey. Her training laid the foundation for a distinguished career in translational regenerative medicine.

Experience

Her extensive clinical training includes urology residency and fellowships in endourology and renal transplantation in leading hospitals across China, including Jiangxi Medical College and the Shanghai First People’s Hospital. Between 1993 and 1995, she gained international exposure as a Fellow in Renal Transplant/Urology and Nephrology at the University of Otago in New Zealand. She later pursued postdoctoral training at the University of Oklahoma Health Sciences Center, further cementing her commitment to pediatric urology and tissue engineering research.

Research

Professionally, Dr. Zhang has held a range of academic positions, beginning as an Assistant Professor and Attending Urologist at Jiangxi Medical College in China. Her research and teaching roles expanded in Europe and the United States, notably at the University of Lausanne and the University of Oklahoma. Since 2006, she has been affiliated with the Wake Forest Institute for Regenerative Medicine, where she was promoted to Associate Professor in 2018. Her leadership and academic service include active grant reviewing roles for NIH (NIDDK), the Sick Kids Foundation (Canada), and ZonMw (Netherlands), reflecting her international reputation and expertise in regenerative urology.

Research

Dr. Zhang’s research interests lie at the intersection of urology, tissue engineering, and regenerative medicine. She is particularly focused on the development of engineered urinary tract tissues and bladder augmentation techniques using biomaterials and stem cells. Her work has had significant implications for pediatric patients with congenital urologic disorders and those requiring bladder reconstruction. Her commitment to translational research is evident in her successful integration of basic science into preclinical and clinical applications, contributing to innovations in scaffold design, cell culture, and organ regeneration.

Awards

Over the years, Dr. Zhang has received recognition for her outstanding contributions. She has been invited to review research proposals for several prominent funding agencies, a testament to her standing in the biomedical research community. Her nominations for competitive national and international grant panels highlight her scientific integrity and leadership in the field of regenerative urology and biomaterials.

Publications

Dr. Zhang has authored numerous peer-reviewed publications, several of which are widely cited. Selected notable publications include:

  1. Zhang Y. et al. (2008). “Tissue engineering of bladder constructs: A comparative study of urothelial cell sources.” Biomaterials, 29(25), 2825–2830. Cited by 412 articles.

  2. Zhang Y. et al. (2011). “A strategy for bladder tissue regeneration using autologous stem cells.” PNAS, 108(28), 11782–11787. Cited by 365 articles.

  3. Zhang Y. et al. (2005). “Urothelial differentiation of human bone marrow-derived stem cells on collagen scaffolds.” Journal of Urology, 173(6), 2046–2050. Cited by 297 articles.

  4. Zhang Y. et al. (2006). “Smooth muscle cell differentiation from bone marrow stem cells for bladder tissue engineering.” Tissue Engineering, 12(7), 1899–1910. Cited by 253 articles.

  5. Zhang Y. et al. (2010). “Engineered bladder tissues from stem cells for functional reconstruction.” Stem Cells and Development, 19(11), 1665–1675. Cited by 228 articles.

  6. Zhang Y. et al. (2014). “Development of a pre-vascularized scaffold for bladder regeneration.” Acta Biomaterialia, 10(7), 2763–2773. Cited by 180 articles.

  7. Zhang Y. et al. (2017). “Biomimetic approaches in bladder tissue regeneration: Current challenges and future perspectives.” Advanced Healthcare Materials, 6(3), 1600734. Cited by 142 articles.

Conclusion

In conclusion, Dr. Yuanyuan Zhang’s career exemplifies the integration of clinical excellence, innovative research, and academic leadership. Her dedication to improving patient outcomes through regenerative strategies has positioned her as a pivotal figure in the field of tissue engineering and urologic regeneration. Her work continues to influence the development of next-generation therapies and to inspire collaborative, cross-disciplinary innovations in biomedical science.